tiprankstipranks
Advertisement
Advertisement

JP:4599 Stock Latest News

StemRIM posts continued loss but secures R&D runway through 2028
Company AnnouncementsStemRIM posts continued loss but secures R&D runway through 2028
1d ago
4599
StemRIM Plans Tax-Efficient Capital Reduction Ahead of July Extraordinary Meeting
PremiumCompany Announcements
StemRIM Plans Tax-Efficient Capital Reduction Ahead of July Extraordinary Meeting
29d ago
4599
StemRIM Highlights Shionogi’s Timelines for Regenerative Drug Redasemtide in DEB and Stroke
PremiumCompany Announcements
StemRIM Highlights Shionogi’s Timelines for Regenerative Drug Redasemtide in DEB and Stroke
30d ago
4599
StemRIM Completes Enrollment in Early-Stage Redasemtide Trial for Ischemic Cardiomyopathy
PremiumCompany Announcements
StemRIM Completes Enrollment in Early-Stage Redasemtide Trial for Ischemic Cardiomyopathy
2M ago
4599
StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
PremiumCompany Announcements
StemRIM Unveils Midterm FY2026 Results and R&D Progress in Regenerative Medicine
3M ago
4599
StemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
PremiumCompany AnnouncementsStemRIM narrows interim loss as it ramps R&D on regenerative drug pipeline
3M ago
4599
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
Premium
Company Announcements
StemRIM Wins Key Patent on Gene Therapy SR-GT1 for Dystrophic Epidermolysis Bullosa
3M ago
4599
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
Premium
Company Announcements
StemRIM Wins Canadian Patent for Redasemtide Use in Cartilage Disorders
4M ago
4599
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
PremiumCompany Announcements
StemRIM Completes Global Phase 2b Enrollment for Stroke Drug Redasemtide
6M ago
4599
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
PremiumCompany Announcements
StemRIM Secures Patent for Innovative Fatty Liver and NASH Therapy in Japan
6M ago
4599
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
PremiumCompany Announcements
StemRIM Inc. Reports Q3 2025 Financial Results Amid Ongoing R&D Investments
6M ago
4599
StemRIM Completes New Share Issuance for Stock Compensation
PremiumCompany Announcements
StemRIM Completes New Share Issuance for Stock Compensation
6M ago
4599
StemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
PremiumCompany AnnouncementsStemRIM Inc. Forms Voluntary Compensation Committee to Enhance Governance
6M ago
4599
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
Premium
Company Announcements
StemRIM Inc. Unveils Revolutionary Regenerative Medicine Plan
7M ago
4599
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
Premium
Company Announcements
StemRIM Inc. Issues New Shares for Restricted Stock Remuneration
7M ago
4599
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
PremiumCompany Announcements
StemRIM Secures Patent for Innovative Gene Therapy Targeting Skin Disorder
8M ago
4599
StemRIM Secures US Patent for Psoriasis Treatment
PremiumCompany Announcements
StemRIM Secures US Patent for Psoriasis Treatment
8M ago
4599
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
PremiumCompany Announcements
StemRIM Inc. Issues Stock Options to Enhance Stakeholder Engagement
9M ago
4599
StemRIM Inc. Proposes Stock Options to Boost Workforce Morale
PremiumCompany Announcements
StemRIM Inc. Proposes Stock Options to Boost Workforce Morale
9M ago
4599
StemRIM Inc. Reports Fiscal Year 2025 Financial Results and Strategic Progress
PremiumCompany AnnouncementsStemRIM Inc. Reports Fiscal Year 2025 Financial Results and Strategic Progress
9M ago
4599
StemRIM Inc. Announces Stock Options for Directors
Premium
Company Announcements
StemRIM Inc. Announces Stock Options for Directors
9M ago
4599
StemRIM Inc. Issues Stock Options to Employees
Premium
Company Announcements
StemRIM Inc. Issues Stock Options to Employees
9M ago
4599

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >